Results 101 to 110 of about 4,397,412 (173)

Nail psoriasis as a severity indicator: results from the PsoReal study

open access: yesPatient Related Outcome Measures, 2010
Marc A Radtke1, Anna K Langenbruch1, I Schäfer1, Katharina Herberger1, Kristian Reich2, Matthias Augustin11Institute for Health Services Research in Dermatology and Nursing, University Medical Center of Hamburg-Eppendorf, Hamburg ...
I Schäfer   +3 more
doaj  

Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study

open access: yesDermatology Practical & Conceptual
Introduction: In patients with plaque type psoriasis (PSO), the progression to psoriatic arthritis (PsA) exacerbates the disease's impact and increases disability risk.
Maria Esposito   +11 more
doaj   +1 more source

Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

open access: yesDermatology and Therapy
Introduction Skin involvement in patients with psoriatic arthritis (PsA) worsens the severity and burden of disease. Ixekizumab (IXE), a selective interleukin (IL)-17A antagonist, was compared to placebo (PBO) in the SPIRIT-P1 (NCT01695239) and SPIRIT-P2
April W. Armstrong   +9 more
doaj   +1 more source

Methods of Outcomes Measurement in Nail Psoriasis [PDF]

open access: yes, 2013
Background: Nail involvement is a common feature of psoriasis, predicting higher disease severity and greater impairment in quality of life. Valid assessment of nail psoriasis is relevant for research and routine clinical use.
Ogilvie, Alexandra, Augustin, Matthias
core  

A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review of literature

open access: yesEgyptian Rheumatology and Rehabilitation
Background The simultaneous occurrence of generalised pustular psoriasis (GPP), acrodermatitis continua of Hallopeau (ACH), and Psoriatic arthritis (PsA) in the same patient is infrequently documented in the literature.
Ritasman Baisya   +2 more
doaj   +1 more source

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year

open access: yesDermatology and Therapy
Introduction Individuals with psoriatic arthritis (PsA) and plaque-type psoriasis and nail involvement have more severe disease and worse quality of life than those without. Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin (
Diamant Thaçi   +10 more
doaj   +1 more source

Efficacy and Tolerability of Brodalumab in 42 Adult Patients With Moderate to Severe Psoriasis: First French Real‐Life Case Series on Hard‐to‐Treat Areas

open access: yesJEADV Clinical Practice
Background Psoriatic hard‐to‐treat areas (scalp, palmoplantar, genital and nails) are associated with lower efficacy, treatment discontinuation and impaired quality of life. Recent biotherapies offer a new perspective for their treatment.
Marc Perrussel, Bruno Sassolas
doaj   +1 more source

Clinical Analysis of Nail Involvement in Psoriasis and Psoriatic Arthritis

open access: yes, 2016
Background: It has been reported that nail psoriasis is common in psoriatic arthritis (PsA) patients, however, studies on the prevalence of PsA with nail psoriasis and the relationship between the severity of the diseases has not previously been reported
���������
core  

Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index. [PDF]

open access: yesFront Med (Lausanne)
Kemenes S   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy